BioNTech schließt Übernahme von Kites Neoantigen-TCR Zelltherapie-Plattform und Produktionsanlagen im amerikanischen Gaithersburg ab
August 04, 2021 07:00 ET
|
BioNTech SE
MAINZ, Deutschland & Santa Monica, USA, 4. August 2021 – BioNTech SE (Nasdaq: BNTX, „BioNTech”) und Kite, ein Unternehmen der Gilead-Gruppe (Nasdaq: GILD, „Kite”) gaben heute bekannt, dass...
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
August 04, 2021 07:00 ET
|
BioNTech SE
MAINZ, Germany & Santa Monica, USA, August 4, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the closing of the acquisition of the...
IBD Announces First Annual Biotech Innovator Awards
October 16, 2017 08:15 ET
|
Investor's Business Daily
Biogen, Celgene, Incyte, Kite Pharma, Loxo Oncology, and Regeneron Pharmaceuticals recognized for outstanding contributions to science and patient health Companies driving advancements to cure...
![CLSA Logo](/news-release/logo/364983/0/364983.jpg?lastModified=12%2F09%2F2016%2023%3A49%3A24&size=2)
Distinguished Life Sciences Leaders to be Honored at CLSA's 2015 Pantheon DiNA Awards Ceremony
November 09, 2015 10:10 ET
|
California Life Sciences Association
SOUTH SAN FRANCISCO, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), the leading voice to drive innovation for California's life sciences sector, today announced...